Roles of autophagy induced by natural compounds in prostate cancer

V Naponelli1, A Modernelli2, S Bettuzzi1

  • 1Department of Biomedicine, Biotechnology and Translational Research, University of Parma, Via Volturno 39/a, 43125 Parma, Italy ; Centre for Molecular and Translational Oncology (COMT), University of Parma, Parco Area delle Scienze 11/a, 43124 Parma, Italy ; National Institute of Biostructure and Biosystems (INBB), Viale Medaglie d'Oro 305, 00136 Rome, Italy.

Insights

Natural compounds may offer new prostate cancer (PCa) treatments by modulating autophagy. This review explores how these compounds affect autophagy in PCa cells for therapeutic potential.

Area of Science:

  • Cellular Biology
  • Oncology
  • Pharmacology

Background:

  • Autophagy is a cellular recycling process crucial for maintaining homeostasis.
  • Dysfunctional autophagy is linked to various diseases, including cancer.
  • Prostate cancer (PCa) involves alterations in autophagy, suggesting its role in disease progression.

Purpose of the Study:

  • To review the current evidence on natural compounds modulating autophagy in prostate cancer (PCa) cells.
  • To explore the therapeutic potential of natural compounds in PCa treatment and prevention.
  • To understand the mechanisms by which natural compounds affect autophagy in PCa.

Main Methods:

  • Literature review of studies investigating natural compounds and autophagy in PCa.
  • Analysis of evidence on autophagy-modulating effects of natural compounds.
  • Synthesis of findings on the role of autophagy in PCa pathogenesis and treatment.

Main Results:

  • Natural compounds show potential in modulating autophagy in PCa cells.
  • Evidence suggests specific anticancer effects of natural compounds via autophagy.
  • Understanding these mechanisms is key for developing novel PCa therapies.

Conclusions:

  • Natural compounds represent a promising avenue for PCa therapy through autophagy modulation.
  • Targeting autophagy with natural compounds could lead to effective chemopreventive and therapeutic strategies for PCa.
  • Further research into the mechanisms of action is warranted for clinical translation.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.2K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
5.1K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K